Management of borderline ovarian tumours
نویسندگان
چکیده
Management of borderline ovarian tumours Pallavi Bagade MRCOG,a Richard Edmondson MD,b,∗ Anitha Nayar FRCPathc aSpecialty Trainee, Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital, Sheriff Hill, Gateshead NE9 6SX, UK bConsultant and Senior Lecturer in Gynaecological Oncology, Northern Gynaecological Oncology Centre, Gateshead, UK cConsultant Pathologist, Department of Pathology, Queen Elizabeth Hospital Woolwich, Stadium Road, London SE18 4QH, UK ∗Correspondence: Richard Edmondson. Email: [email protected]
منابع مشابه
Fertility sparing treatment in borderline ovarian tumours
Borderline ovarian tumours are low malignant potential tumours. They represent 10-15% of all epithelial ovarian malignancies. Patients with this type of tumour are younger at the time of diagnosis than patients with invasive ovarian cancer. Most of them are diagnosed in the early stages and have an excellent prognosis. It has been quite clearly established that the majority of borderline ovaria...
متن کاملFull Term Pregnancy after Recurrent Borderline Epithelial Ovarian Tumor
Incidence of borderline ovarian tumours (BOTs) ranges from 10-15% of all ovarian tumours. They affect a younger age group than the ovarian carcinoma and have a much better prognosis. Over the last decades, the management of borderline ovarian tumors has changed from radical surgery to more fertility oriented therapy. Fertility-sparing surgery is defined as surgery with complete staging, but whe...
متن کاملMetadherin, p50, and p65 Expression in Epithelial Ovarian Neoplasms: An Immunohistochemical Study
NF-κB signaling promotes cancer progression in a large number of malignancies. Metadherin, a coactivator of the NF-κB transcription complex, was recently identified to regulate different signaling pathways that are closely related to cancer. We assessed the immunohistochemical expression of p50, p65, and metadherin in 30 ovarian carcinomas, 15 borderline ovarian tumours, and 31 benign ovarian c...
متن کاملDNA Cytometry and Nuclear Morphometry in Ovarian Benign, Borderline and Malignant Tumors
BACKDROUND Ovarian carcinoma is a leading cause of death in gynecological malignancy. Ovarian surface epithelial serous and mucinous tumours are classified as benign, borderline, and malignant. The identification of borderline tumours most likely to act aggressively remains an important clinical issue. AIM This work aimed to study DNA ploidy and nuclear area in ovarian serous and mucinous; be...
متن کاملAccuracy of intra-operative frozen section in the diagnosis of ovarian tumours.
OBJECTIVES To compare frozen-section results with definitive histopathological results of ovarian tumours diagnosed intra operatively at the Zonguldak Maternity Hospital, Zonguldak, Turkey. METHODS The definitive histopathological results of 278 patients who underwent surgery between January 2002 and December 2008 for ovarian masses and on whom frozen sectioning was performed were evaluated r...
متن کامل